Subcutaneous alemtuzumab may be useful in the treatment of steroid-refractory acute graft-versus-host disease

被引：0
|
作者：
Gomez-Almaguer, David [1 ]
Ruiz-Arguelles, Guillermo J. [2 ]
Gonzalez-Llano, Oscar [1 ]
Guttierez-Aguire, Homero C. [1 ]
Cantu-Rodriguez, Olga G. [1 ]
Jaime-Perez, Jose C. [1 ]
Giralt, Sergio [3 ]
机构：
[1] Hosp Univ, Monterrey, Mexico
[2] Ctr Hematol & Med Interna Puebla, Puebla, Mexico
[3] MD Anderson Canc Ctr, Houston, TX USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.2983.2983
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2983
引用
收藏
页码：876A / 876A
页数：1
相关论文
共 50 条
  • [21] Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease
    Philippen, Lennart
    Schub, Natalie
    Guenther, Andreas
    Cario, Gunnar
    Schrappe, Martin
    Repp, Roland
    Gramatzki, Martin
    BONE MARROW TRANSPLANTATION, 2024, 59 (01) : 153 - 155
  • [22] Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
    Malard, Florent
    Huang, Xiao-Jun
    Sim, Joycelyn P. Y.
    LEUKEMIA, 2020, 34 (05) : 1229 - 1240
  • [23] Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host disease
    Bordigoni, Pierre
    Dimicoli, Sophie
    Clement, Laurence
    Baumann, Cedric
    Salmon, Alexandra
    Witz, Francis
    Feugier, Pierre
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (03) : 382 - 385
  • [24] Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
    Florent Malard
    Xiao-Jun Huang
    Joycelyn P. Y. Sim
    Leukemia, 2020, 34 : 1229 - 1240
  • [25] Alemtuzumab (MabCampath) can successfully treat steroid-refractory acute graft-versus-host disease (aGVHD).
    Carella, AM
    Beltrami, G
    Scalzulli, PR
    Lerma, E
    BLOOD, 2002, 100 (11) : 422A - 423A
  • [26] Beyond ruxolitinib in steroid-refractory acute graft-versus-host disease
    Lee, Catherine J.
    Pusic, Iskra
    Savani, Bipin N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 306 - 307
  • [27] Infliximab for Managing Steroid-Refractory Acute Graft-versus-Host Disease
    Pidala, Joseph
    Kim, Jongphil
    Field, Teresa
    McBride, Ali
    Kharfan-Dabaja, Mohamed
    Perkins, Janelle
    Fernandez, Hugo
    Perez, Lia
    Ayala, Ernesto
    Anasetti, Claudio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) : 1116 - 1121
  • [28] Steroid-Refractory Acute Graft-versus-Host Disease: Is There an Effective Therapy?
    Antin, Joseph H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : 146 - 148
  • [29] Novel strategies for steroid-refractory acute graft-versus-host disease
    Bolaños-Meade, J
    Vogelsang, GB
    CURRENT OPINION IN HEMATOLOGY, 2005, 12 (01) : 40 - 44
  • [30] Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease
    Krejci, M
    Doubek, M
    Buehler, T
    Brychtova, Y
    Vorlicek, J
    Mayer, J
    ANNALS OF HEMATOLOGY, 2005, 84 (10) : 681 - 685
12345